Lincoln Pharma gets patent for anti-malarial drug in India
New Delhi: Lincoln Pharmaceuticals has been awarded a patent for an anti-malarial drug in India, the company said.
The patent has been awarded by the Indian government for an Arteether injection to treat malaria, according to a BSE filing.
The drug is painless and gives faster relief to the patients, Lincoln Pharma said.
The company expects a significant rise in the revenue from exports to Africa after the introduction of this injection in the African market.
"With the introduction of this injection in African countries, where the total anti-malarial market is Rs 586 crore, the company expects to increase revenue from Africa by Rs 35-40 crore," it added.
At present, the company's anti-malarial drug exports to Africa amounts to Rs 50 crore.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd